These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 580590)

  • 1. [Clinical study of meproscillarin rates of inactivation and persistence, bioavailability and maintenance dose].
    Herken H; Brandes J
    Arzneimittelforschung; 1978; 28(3a):557-60. PubMed ID: 580590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term study with the novel cardiac glycoside meproscillarin (author's transl)].
    Eckardt A; Koch W; Safer A
    Arzneimittelforschung; 1978; 28(3a):570-3. PubMed ID: 348206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the possible meproscillarin accumulation in patients with impaired renal function (author's transl)].
    Twittenhoff WD; Brittinger WD; Deckert DW; Belz GG; Schubert I
    Arzneimittelforschung; 1978; 28(3a):562-5. PubMed ID: 580591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elimination rate of meproscillarin following repeated application in patients with reduced renal function (author's transl)].
    Beckmann H; Belz GG; Quellhorst E
    Arzneimittelforschung; 1978; 28(3a):565-7. PubMed ID: 580592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the disposition of meproscillarin in rat and dog (author's transl)].
    Weymann J; Schenk G; Kesselring K
    Arzneimittelforschung; 1978; 28(3a):520-6. PubMed ID: 580582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the development of an oral preparation of meproscillarin (author's transl)].
    Einig H; Mayer D
    Arzneimittelforschung; 1978; 28(3a):527-31. PubMed ID: 580583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical observations during accumulative oral glycoside therapy with meproscillarin (author's transl)].
    Pozenel H
    Arzneimittelforschung; 1978; 28(3a):560-2. PubMed ID: 348205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of meproscillarin on human left ventricular function (author's transl)].
    Turina J; Krayenbühl HP
    Arzneimittelforschung; 1978; 28(3a):555-7. PubMed ID: 580589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolism of meproscillarin in man (author's transl)].
    Rietbrock N
    Arzneimittelforschung; 1978; 28(3a):540-5. PubMed ID: 580585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Elimination of meproscillarin by hemoperfusion (author's transl)].
    Rupp M; Brass H; Belz GG
    Arzneimittelforschung; 1978; 28(3a):567-9. PubMed ID: 580593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary hemodynamic studies on the activity of meproscillarin (author's transl)].
    Klein WW; Pavek P
    Arzneimittelforschung; 1978; 28(3a):553-5. PubMed ID: 580588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Labelling meproscillarin with tritium at the C-19 position (author's transl)].
    Schenk G; Albrecht HP; Lietz H
    Arzneimittelforschung; 1978; 28(3a):518-9. PubMed ID: 580581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of meproscillarin on left ventricular hemodynamics (author's transl)].
    Pachinger O; Probst P
    Arzneimittelforschung; 1978; 28(3a):550-2. PubMed ID: 580587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meproscillarin, a new semisynthetic cardiac glycoside/chemistry and physical properties (author's transl)].
    Kubinyi H
    Arzneimittelforschung; 1978; 28(3a):493-5. PubMed ID: 580577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of cardiac glycosides and clinical consequences].
    Rietbrock N; Kuhlmann J; Vöhringer HF
    Fortschr Med; 1977 Apr; 95(14):909-15, 951-4. PubMed ID: 856698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modifying factors in carciac glycoside therapy].
    Krebs R
    Med Klin; 1976 Oct; 71(42):1759-70. PubMed ID: 790134
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiac effects, relative enteral effectiveness and rate of inactivation of the cardiac glycoside meproscillarin].
    Raschack M; Haas H; Neugebauer G; Sipos J
    Arzneimittelforschung; 1978; 28(3a):495-502. PubMed ID: 580578
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effective concentration and dosage for cardiac glycosides].
    Weiss M; Förster W
    Z Gesamte Inn Med; 1980 Jan; 35(1):1-7. PubMed ID: 6996345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Introduction to clinical pharmacodynamics and pharmacokinetics of cardiac glycosides].
    Kudrin AN; Namakanov BA; Davydova ON
    Sov Med; 1981; (11):70-4. PubMed ID: 7038899
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic equivalence and inequivalence of chemically identical substances using cardiac glycosides for an example (author's transpl)].
    Rietbrock N
    Arzneimittelforschung; 1976; 26(1A):135-46. PubMed ID: 947193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.